Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Health Canada approves obesity drug Wegovy
Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults
Wegovy approved in Canada to combat risk of non fatal-heart attack
Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.
Health Canada approves Wegovy® (semaglutide injection) to reduce the risk of non-fatal myocardial infarction
Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial infarction in adults with established cardiovascular disease and BMI equal to or greater than 27 kg/m2.
Health Canada approves obesity drug Wegovy as a way to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults
Health Matters: Wegovy approved to reduce heart attack risk
Novo Nordisk says Health Canada has approved its weight loss drug Wegovy to reduce the risk of heart attacks in some adults. Kyle Benning has the details and more in Health Matters for Nov. 27, 2024.
8h
Why some people don’t lose weight with Wegovy
Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
The Varsity
12d
Ozempic and Wegovy are changing the science of weight loss
Though these drugs were originally developed for managing blood sugar in people with type 2 diabetes, researchers soon ...
9d
Mental health worsening across Canada, access to care is uneven, report says
Inability to get needed mental health care is a reality facing many people in this country, according to The State of Mental ...
9d
Novo Nordisk sells hit weight-loss drug in China—at fraction of US price
Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a ...
9d
on MSN
Popular weight-loss drug Wegovy goes on sale in China
Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...
The Canadian Press on MSN
1d
Measles outbreak: Almost 30 per cent of N.B. kindergartners not fully vaccinated
The most recent figures from New Brunswick's Health Department are notable given the ongoing outbreak of measles in the ...
Voice Online
1d
Health Canada approves Wegovy (semaglutide injection) to reduce risk of non-fatal myocardial infarction
NOVO Nordisk on Wednesday announced that Wegovy (semaglutide injection) is now approved to reduce the risk of non-fatal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback